Managers / Q1 2022 · view latest →
Advantage Alpha Capital Partners LP
CIK 0001762344 · 1160 BATTERY STREET, EAST BUILDING, SUITE 100, SAN FRANCISCO, CA, 94111 · 4153437077
Summary
Advantage Alpha Capital Partners LP reported $668M in U.S.-listed holdings across 126 positions for Q1 2022.
Its largest position, DAR, represents 3.2% of the portfolio.
Compared with Q4 2021, the fund opened 8 new positions and exited 12.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 94.2% · $630M
- Other · 5.8% · $38M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SITESITEONE LANDSCAPE SUPPLY INC | NEW | +52.6K | 52.6K | +$9M | $9M |
| NCNONCINO INC | NEW | +185.4K | 185.4K | +$8M | $8M |
| AGILON HEALTH INC | NEW | +295.6K | 295.6K | +$7M | $7M |
| AXONAXON ENTERPRISE INC | NEW | +29.2K | 29.2K | +$4M | $4M |
| LSTRLANDSTAR SYS INC | NEW | +26.0K | 26.0K | +$4M | $4M |
| OLO INC | NEW | +255.7K | 255.7K | +$3M | $3M |
| KIDSORTHOPEDIATRICS CORP | NEW | +51.0K | 51.0K | +$3M | $3M |
| DOCNDIGITALOCEAN HLDGS INC | NEW | +40.2K | 40.2K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $0 | 1 | Jan 22, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $332M | 130 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $371M | 119 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $408M | 146 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $423M | 153 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $439M | 167 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $458M | 154 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $532M | 158 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $528M | 154 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $476M | 93 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $500M | 88 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $480M | 115 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $493M | 101 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $544M | 89 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $579M | 115 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $668M | 126 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $702M | 130 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $549M | 132 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $519M | 131 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $475M | 130 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $457M | 106 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $433M | 83 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $427M | 88 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $281M | 91 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $371M | 90 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.